Detailed answers about ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED founded?
ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED was officially incorporated on 11 October 2023 and is registered under company number 15204622. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED?
ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED do?
ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED's registered address?
The registered office address of ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED is WINDSOR HOUSE, BAYSHILL ROAD, CHELTENHAM, GLOUCESTERSHIRE, UNITED KINGDOM, GL50 3AT. This is the official address filed with Companies House for legal and statutory correspondence.
Is ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED financially stable?
The most recent accounts for ANGIOVISIUM, DIAGNOSTICS AND SOLUTIONS LIMITED were made up to 31 October 2024, filed as MICRO ENTITY. Next accounts are due by 31 July 2026.